| Vinod Pradeepkumar Mitta, MD, MPH | |
|
150 Greenwich St Fl 29, New York, NY 10007-2381 | |
| (310) 227-5687 | |
| Not Available |
| Full Name | Vinod Pradeepkumar Mitta |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 150 Greenwich St Fl 29, New York, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942590021 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 276469 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Vinod Pradeepkumar Mitta, MD, MPH 2093 Philadelphia Pike # 8384, Claymont, DE 19703-2424 Ph: () - | Vinod Pradeepkumar Mitta, MD, MPH 150 Greenwich St Fl 29, New York, NY 10007-2381 Ph: (310) 227-5687 |
News Archive
The Institute for Quality and Efficiency in Health Care (IQWiG) has investigated the reliability of diagnosing bronchial asthma in children aged between 2 and 5 years, and the benefit that the test results can have for these patients. IQWiG published its final report in August 2009. According to the report, the available studies do not reveal any diagnostic procedure to be particularly suitable. It also remains unclear whether the treatment given based on the test results can benefit the patients.
Those with asthma are experiencing less asthma control related to an increase in using household disinfectants - known asthma triggers - because of COVID-19, according to a survey co-conducted by University of Illinois Chicago researchers.
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues from the UF Shands Cancer Center in Gainesville, Fla., have found that cases of myeloid malignancies are being underreported since a change in registry protocols and laboratory practices starting in 2001.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).
› Verified 1 days ago
Gerard P Varlotta, D.O Preventive Medicine Medicare: May Accept Medicare Assignments Practice Location: 20 E 46th St Rm 304, New York, NY 10017 Phone: 212-725-1800 | |
Dr. Thomas Gregory Mckelvey Jr., M.D., M.P.H. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1 World Trade Ctr Fl 80, New York, NY 10007 Phone: 646-584-7213 | |
Dr. Allen Robert Feldman, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 W End Ave, 8b, New York, NY 10024 Phone: 212-769-4629 Fax: 212-769-4629 | |
Dr. John C Rausch, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 3959 Broadway, Columbia Unversity Department Pediatric, New York, NY 10032 Phone: 212-304-7250 Fax: 212-544-1974 | |
Dr. Eugenio Cruz Mateo, MD,MPH&TM Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 125 White St, New York, NY 10013 Phone: 212-225-1482 Fax: 212-225-1489 | |
Dr. Robert Raymond Boesch, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 290 Broadway, Suite 215, New York, NY 10007 Phone: 212-637-3003 Fax: 212-637-5155 | |
Dr. Kelly Andre Jarrett, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 2006 Madison Ave, New York, NY 10035 Phone: 212-633-0815 |